nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—Thalidomide—leprosy	0.451	1	CrCtD
Lenalidomide—Pomalidomide—Thalidomide—leprosy	0.265	1	CrCrCtD
Lenalidomide—CRBN—Thalidomide—leprosy	0.199	0.851	CbGbCtD
Lenalidomide—PTGS2—Thalidomide—leprosy	0.0164	0.0701	CbGbCtD
Lenalidomide—PTGS2—Dapsone—leprosy	0.0131	0.0561	CbGbCtD
Lenalidomide—ABCB1—Rifampicin—leprosy	0.00524	0.0224	CbGbCtD
Lenalidomide—TNFSF11—hindlimb—leprosy	0.00491	0.278	CbGeAlD
Lenalidomide—TNFSF11—appendage—leprosy	0.00422	0.238	CbGeAlD
Lenalidomide—CDH5—blood vessel—leprosy	0.00177	0.0999	CbGeAlD
Lenalidomide—Pomalidomide—TNF—leprosy	0.000879	0.608	CrCbGaD
Lenalidomide—Acute myeloid leukaemia—Thalidomide—leprosy	0.000868	0.0278	CcSEcCtD
Lenalidomide—TNFSF11—tendon—leprosy	0.000827	0.0468	CbGeAlD
Lenalidomide—Mood alteration NOS—Thalidomide—leprosy	0.00071	0.0228	CcSEcCtD
Lenalidomide—Myelodysplastic syndrome—Thalidomide—leprosy	0.00071	0.0228	CcSEcCtD
Lenalidomide—TNFSF11—testis—leprosy	0.000685	0.0387	CbGeAlD
Lenalidomide—Teratogenicity—Thalidomide—leprosy	0.00068	0.0218	CcSEcCtD
Lenalidomide—Disease progression—Thalidomide—leprosy	0.000653	0.0209	CcSEcCtD
Lenalidomide—PTGS2—hindlimb—leprosy	0.000639	0.0362	CbGeAlD
Lenalidomide—CDH5—tendon—leprosy	0.000622	0.0352	CbGeAlD
Lenalidomide—Mental status changes—Thalidomide—leprosy	0.000605	0.0194	CcSEcCtD
Lenalidomide—Swelling face—Dapsone—leprosy	0.000585	0.0187	CcSEcCtD
Lenalidomide—Thalidomide—TNF—leprosy	0.000567	0.392	CrCbGaD
Lenalidomide—PTGS2—appendage—leprosy	0.000549	0.031	CbGeAlD
Lenalidomide—Thromboembolic event—Thalidomide—leprosy	0.000529	0.017	CcSEcCtD
Lenalidomide—CDH5—testis—leprosy	0.000515	0.0291	CbGeAlD
Lenalidomide—Tumour lysis syndrome—Thalidomide—leprosy	0.000514	0.0165	CcSEcCtD
Lenalidomide—CDH5—nervous system—leprosy	0.000506	0.0286	CbGeAlD
Lenalidomide—Peripheral sensory neuropathy—Thalidomide—leprosy	0.000499	0.016	CcSEcCtD
Lenalidomide—Acute leukaemia—Thalidomide—leprosy	0.000499	0.016	CcSEcCtD
Lenalidomide—Septic shock—Thalidomide—leprosy	0.000472	0.0151	CcSEcCtD
Lenalidomide—PTGS2—skin epidermis—leprosy	0.000456	0.0258	CbGeAlD
Lenalidomide—Polyneuropathy—Thalidomide—leprosy	0.000437	0.014	CcSEcCtD
Lenalidomide—CRBN—tendon—leprosy	0.000395	0.0224	CbGeAlD
Lenalidomide—Intestinal perforation—Thalidomide—leprosy	0.000361	0.0116	CcSEcCtD
Lenalidomide—Rales—Thalidomide—leprosy	0.000347	0.0111	CcSEcCtD
Lenalidomide—CRBN—testis—leprosy	0.000327	0.0185	CbGeAlD
Lenalidomide—CRBN—nervous system—leprosy	0.000321	0.0182	CbGeAlD
Lenalidomide—Altered state of consciousness—Thalidomide—leprosy	0.000309	0.0099	CcSEcCtD
Lenalidomide—PTGS2—blood vessel—leprosy	0.000305	0.0173	CbGeAlD
Lenalidomide—Aphthous stomatitis—Thalidomide—leprosy	0.000304	0.00975	CcSEcCtD
Lenalidomide—Cerebral ischaemia—Thalidomide—leprosy	0.000295	0.00946	CcSEcCtD
Lenalidomide—Embolism venous—Thalidomide—leprosy	0.000282	0.00906	CcSEcCtD
Lenalidomide—Transient ischaemic attack—Thalidomide—leprosy	0.000282	0.00906	CcSEcCtD
Lenalidomide—Lymphopenia—Thalidomide—leprosy	0.000279	0.00893	CcSEcCtD
Lenalidomide—Foetor hepaticus—Thalidomide—leprosy	0.000251	0.00805	CcSEcCtD
Lenalidomide—Febrile neutropenia—Thalidomide—leprosy	0.000237	0.0076	CcSEcCtD
Lenalidomide—Deep vein thrombosis—Thalidomide—leprosy	0.000234	0.00751	CcSEcCtD
Lenalidomide—Toothache—Thalidomide—leprosy	0.000234	0.00751	CcSEcCtD
Lenalidomide—Oral candidiasis—Thalidomide—leprosy	0.000224	0.00719	CcSEcCtD
Lenalidomide—Hypomagnesaemia—Thalidomide—leprosy	0.000224	0.00719	CcSEcCtD
Lenalidomide—Hypothyroidism—Thalidomide—leprosy	0.000222	0.00712	CcSEcCtD
Lenalidomide—Embolism—Thalidomide—leprosy	0.000222	0.00712	CcSEcCtD
Lenalidomide—Liver disorder—Thalidomide—leprosy	0.000209	0.0067	CcSEcCtD
Lenalidomide—Burning sensation—Thalidomide—leprosy	0.000205	0.00658	CcSEcCtD
Lenalidomide—Thrombosis—Thalidomide—leprosy	0.000201	0.00646	CcSEcCtD
Lenalidomide—Interstitial lung disease—Thalidomide—leprosy	0.000201	0.00646	CcSEcCtD
Lenalidomide—Metrorrhagia—Thalidomide—leprosy	0.0002	0.0064	CcSEcCtD
Lenalidomide—Neuritis—Thalidomide—leprosy	0.000191	0.00612	CcSEcCtD
Lenalidomide—ABCB1—blood vessel—leprosy	0.000189	0.0107	CbGeAlD
Lenalidomide—Cholestasis—Thalidomide—leprosy	0.000188	0.00602	CcSEcCtD
Lenalidomide—Pleural effusion—Thalidomide—leprosy	0.000186	0.00597	CcSEcCtD
Lenalidomide—Nasopharyngitis—Dapsone—leprosy	0.000181	0.00579	CcSEcCtD
Lenalidomide—Rash pustular—Thalidomide—leprosy	0.000179	0.00573	CcSEcCtD
Lenalidomide—Muscular weakness—Dapsone—leprosy	0.000178	0.00572	CcSEcCtD
Lenalidomide—Myocardial ischaemia—Thalidomide—leprosy	0.000177	0.00569	CcSEcCtD
Lenalidomide—Influenza—Dapsone—leprosy	0.000175	0.0056	CcSEcCtD
Lenalidomide—Petechiae—Thalidomide—leprosy	0.000173	0.00555	CcSEcCtD
Lenalidomide—Endocrine disorder—Thalidomide—leprosy	0.000172	0.00551	CcSEcCtD
Lenalidomide—Pancreatitis—Dapsone—leprosy	0.000171	0.00549	CcSEcCtD
Lenalidomide—Amenorrhoea—Thalidomide—leprosy	0.000162	0.0052	CcSEcCtD
Lenalidomide—Photosensitivity reaction—Dapsone—leprosy	0.000159	0.00511	CcSEcCtD
Lenalidomide—Musculoskeletal stiffness—Thalidomide—leprosy	0.000159	0.00509	CcSEcCtD
Lenalidomide—Skin discolouration—Thalidomide—leprosy	0.000158	0.00506	CcSEcCtD
Lenalidomide—Cellulitis—Thalidomide—leprosy	0.000157	0.00503	CcSEcCtD
Lenalidomide—Hyperbilirubinaemia—Thalidomide—leprosy	0.000157	0.00503	CcSEcCtD
Lenalidomide—Hypocalcaemia—Thalidomide—leprosy	0.000156	0.00499	CcSEcCtD
Lenalidomide—Herpes simplex—Thalidomide—leprosy	0.000155	0.00496	CcSEcCtD
Lenalidomide—Hyperuricaemia—Thalidomide—leprosy	0.000154	0.00493	CcSEcCtD
Lenalidomide—Neuropathy peripheral—Dapsone—leprosy	0.000153	0.0049	CcSEcCtD
Lenalidomide—Hypercholesterolaemia—Thalidomide—leprosy	0.000151	0.00483	CcSEcCtD
Lenalidomide—Hearing impaired—Thalidomide—leprosy	0.00015	0.0048	CcSEcCtD
Lenalidomide—Bone pain—Thalidomide—leprosy	0.000149	0.00477	CcSEcCtD
Lenalidomide—Sinusitis—Dapsone—leprosy	0.000146	0.00469	CcSEcCtD
Lenalidomide—Gait disturbance—Thalidomide—leprosy	0.000146	0.00468	CcSEcCtD
Lenalidomide—Blood uric acid increased—Thalidomide—leprosy	0.000145	0.00465	CcSEcCtD
Lenalidomide—Neck pain—Thalidomide—leprosy	0.000144	0.00463	CcSEcCtD
Lenalidomide—Hepatocellular injury—Thalidomide—leprosy	0.000143	0.00457	CcSEcCtD
Lenalidomide—Pulmonary embolism—Thalidomide—leprosy	0.000143	0.00457	CcSEcCtD
Lenalidomide—PTGS2—skin of body—leprosy	0.000141	0.008	CbGeAlD
Lenalidomide—Pharyngitis—Dapsone—leprosy	0.000139	0.00445	CcSEcCtD
Lenalidomide—Depressed level of consciousness—Thalidomide—leprosy	0.000138	0.00441	CcSEcCtD
Lenalidomide—Colitis—Thalidomide—leprosy	0.000137	0.00439	CcSEcCtD
Lenalidomide—Candida infection—Thalidomide—leprosy	0.000136	0.00436	CcSEcCtD
Lenalidomide—Neuropathy—Thalidomide—leprosy	0.000134	0.00429	CcSEcCtD
Lenalidomide—Dry eye—Thalidomide—leprosy	0.000132	0.00422	CcSEcCtD
Lenalidomide—Tinnitus—Dapsone—leprosy	0.00013	0.00418	CcSEcCtD
Lenalidomide—Gynaecomastia—Thalidomide—leprosy	0.000128	0.00409	CcSEcCtD
Lenalidomide—Pulmonary oedema—Thalidomide—leprosy	0.000127	0.00407	CcSEcCtD
Lenalidomide—Sepsis—Thalidomide—leprosy	0.000124	0.00397	CcSEcCtD
Lenalidomide—Erythema—Dapsone—leprosy	0.000122	0.0039	CcSEcCtD
Lenalidomide—Lymphadenopathy—Thalidomide—leprosy	0.000121	0.00389	CcSEcCtD
Lenalidomide—Thrombophlebitis—Thalidomide—leprosy	0.00012	0.00383	CcSEcCtD
Lenalidomide—Diabetes mellitus—Thalidomide—leprosy	0.000119	0.00381	CcSEcCtD
Lenalidomide—Gastroenteritis—Thalidomide—leprosy	0.000117	0.00374	CcSEcCtD
Lenalidomide—Deafness—Thalidomide—leprosy	0.000116	0.00371	CcSEcCtD
Lenalidomide—Eczema—Thalidomide—leprosy	0.000115	0.00369	CcSEcCtD
Lenalidomide—Vision blurred—Dapsone—leprosy	0.000115	0.00368	CcSEcCtD
Lenalidomide—Cardiac failure congestive—Thalidomide—leprosy	0.000114	0.00366	CcSEcCtD
Lenalidomide—Renal failure acute—Thalidomide—leprosy	0.000112	0.00359	CcSEcCtD
Lenalidomide—Vertigo—Dapsone—leprosy	0.000109	0.00351	CcSEcCtD
Lenalidomide—Atrial fibrillation—Thalidomide—leprosy	0.000109	0.0035	CcSEcCtD
Lenalidomide—Visual disturbance—Thalidomide—leprosy	0.000109	0.0035	CcSEcCtD
Lenalidomide—PTGS2—tendon—leprosy	0.000108	0.00609	CbGeAlD
Lenalidomide—Arthritis—Thalidomide—leprosy	0.000106	0.00341	CcSEcCtD
Lenalidomide—Cough—Dapsone—leprosy	0.000106	0.00341	CcSEcCtD
Lenalidomide—Hypoglycaemia—Thalidomide—leprosy	0.000106	0.0034	CcSEcCtD
Lenalidomide—Cardiac failure—Thalidomide—leprosy	0.000106	0.0034	CcSEcCtD
Lenalidomide—Lethargy—Thalidomide—leprosy	0.000106	0.00339	CcSEcCtD
Lenalidomide—Cerebrovascular accident—Thalidomide—leprosy	0.000106	0.00339	CcSEcCtD
Lenalidomide—Hyponatraemia—Thalidomide—leprosy	0.000104	0.00333	CcSEcCtD
Lenalidomide—Pain in extremity—Thalidomide—leprosy	0.000103	0.00332	CcSEcCtD
Lenalidomide—Diplopia—Thalidomide—leprosy	0.000103	0.00332	CcSEcCtD
Lenalidomide—Osteoarthritis—Thalidomide—leprosy	0.000103	0.00332	CcSEcCtD
Lenalidomide—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000103	0.00332	CcSEcCtD
Lenalidomide—Migraine—Thalidomide—leprosy	0.000102	0.00327	CcSEcCtD
Lenalidomide—Affect lability—Thalidomide—leprosy	0.000102	0.00327	CcSEcCtD
Lenalidomide—Face oedema—Thalidomide—leprosy	9.99e-05	0.0032	CcSEcCtD
Lenalidomide—Cardiac arrest—Thalidomide—leprosy	9.84e-05	0.00315	CcSEcCtD
Lenalidomide—Mood swings—Thalidomide—leprosy	9.8e-05	0.00314	CcSEcCtD
Lenalidomide—Ataxia—Thalidomide—leprosy	9.73e-05	0.00312	CcSEcCtD
Lenalidomide—Tachycardia—Dapsone—leprosy	9.7e-05	0.00311	CcSEcCtD
Lenalidomide—Blood creatinine increased—Thalidomide—leprosy	9.69e-05	0.00311	CcSEcCtD
Lenalidomide—Dehydration—Thalidomide—leprosy	9.62e-05	0.00309	CcSEcCtD
Lenalidomide—Liver function test abnormal—Thalidomide—leprosy	9.55e-05	0.00306	CcSEcCtD
Lenalidomide—Dry skin—Thalidomide—leprosy	9.48e-05	0.00304	CcSEcCtD
Lenalidomide—Hypokalaemia—Thalidomide—leprosy	9.42e-05	0.00302	CcSEcCtD
Lenalidomide—Breast disorder—Thalidomide—leprosy	9.35e-05	0.003	CcSEcCtD
Lenalidomide—Aspartate aminotransferase increased—Thalidomide—leprosy	9.32e-05	0.00299	CcSEcCtD
Lenalidomide—Cramp muscle—Thalidomide—leprosy	9.32e-05	0.00299	CcSEcCtD
Lenalidomide—Toxic epidermal necrolysis—Thalidomide—leprosy	9.32e-05	0.00299	CcSEcCtD
Lenalidomide—Muscular weakness—Thalidomide—leprosy	9.13e-05	0.00293	CcSEcCtD
Lenalidomide—Alanine aminotransferase increased—Thalidomide—leprosy	9.13e-05	0.00293	CcSEcCtD
Lenalidomide—Abdominal distension—Thalidomide—leprosy	9e-05	0.00289	CcSEcCtD
Lenalidomide—Insomnia—Dapsone—leprosy	8.99e-05	0.00288	CcSEcCtD
Lenalidomide—Dysphagia—Thalidomide—leprosy	8.94e-05	0.00287	CcSEcCtD
Lenalidomide—Influenza—Thalidomide—leprosy	8.94e-05	0.00287	CcSEcCtD
Lenalidomide—Pancreatitis—Thalidomide—leprosy	8.77e-05	0.00281	CcSEcCtD
Lenalidomide—PTGS2—nervous system—leprosy	8.75e-05	0.00495	CbGeAlD
Lenalidomide—Angina pectoris—Thalidomide—leprosy	8.71e-05	0.00279	CcSEcCtD
Lenalidomide—Bronchitis—Thalidomide—leprosy	8.6e-05	0.00276	CcSEcCtD
Lenalidomide—Pancytopenia—Thalidomide—leprosy	8.49e-05	0.00272	CcSEcCtD
Lenalidomide—Neutropenia—Thalidomide—leprosy	8.36e-05	0.00268	CcSEcCtD
Lenalidomide—Upper respiratory tract infection—Thalidomide—leprosy	8.31e-05	0.00266	CcSEcCtD
Lenalidomide—Pollakiuria—Thalidomide—leprosy	8.26e-05	0.00265	CcSEcCtD
Lenalidomide—Erectile dysfunction—Thalidomide—leprosy	8.24e-05	0.00264	CcSEcCtD
Lenalidomide—Photosensitivity reaction—Thalidomide—leprosy	8.16e-05	0.00262	CcSEcCtD
Lenalidomide—Weight increased—Thalidomide—leprosy	8.14e-05	0.00261	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Dapsone—leprosy	8.12e-05	0.0026	CcSEcCtD
Lenalidomide—Weight decreased—Thalidomide—leprosy	8.09e-05	0.00259	CcSEcCtD
Lenalidomide—Hyperglycaemia—Thalidomide—leprosy	8.07e-05	0.00259	CcSEcCtD
Lenalidomide—Pneumonia—Thalidomide—leprosy	8.02e-05	0.00257	CcSEcCtD
Lenalidomide—Infestation—Thalidomide—leprosy	7.97e-05	0.00256	CcSEcCtD
Lenalidomide—Infestation NOS—Thalidomide—leprosy	7.97e-05	0.00256	CcSEcCtD
Lenalidomide—Depression—Thalidomide—leprosy	7.95e-05	0.00255	CcSEcCtD
Lenalidomide—Stevens-Johnson syndrome—Thalidomide—leprosy	7.91e-05	0.00253	CcSEcCtD
Lenalidomide—Acute coronary syndrome—Thalidomide—leprosy	7.86e-05	0.00252	CcSEcCtD
Lenalidomide—Abdominal pain—Dapsone—leprosy	7.85e-05	0.00252	CcSEcCtD
Lenalidomide—Body temperature increased—Dapsone—leprosy	7.85e-05	0.00252	CcSEcCtD
Lenalidomide—Renal failure—Thalidomide—leprosy	7.84e-05	0.00251	CcSEcCtD
Lenalidomide—Myocardial infarction—Thalidomide—leprosy	7.82e-05	0.00251	CcSEcCtD
Lenalidomide—Neuropathy peripheral—Thalidomide—leprosy	7.82e-05	0.00251	CcSEcCtD
Lenalidomide—Stomatitis—Thalidomide—leprosy	7.77e-05	0.00249	CcSEcCtD
Lenalidomide—Conjunctivitis—Thalidomide—leprosy	7.75e-05	0.00248	CcSEcCtD
Lenalidomide—Sweating—Thalidomide—leprosy	7.64e-05	0.00245	CcSEcCtD
Lenalidomide—Haematuria—Thalidomide—leprosy	7.6e-05	0.00244	CcSEcCtD
Lenalidomide—Epistaxis—Thalidomide—leprosy	7.52e-05	0.00241	CcSEcCtD
Lenalidomide—Sinusitis—Thalidomide—leprosy	7.48e-05	0.0024	CcSEcCtD
Lenalidomide—Agranulocytosis—Thalidomide—leprosy	7.44e-05	0.00239	CcSEcCtD
Lenalidomide—Bradycardia—Thalidomide—leprosy	7.29e-05	0.00234	CcSEcCtD
Lenalidomide—Rhinitis—Thalidomide—leprosy	7.18e-05	0.0023	CcSEcCtD
Lenalidomide—Hepatitis—Thalidomide—leprosy	7.16e-05	0.00229	CcSEcCtD
Lenalidomide—Hypoaesthesia—Thalidomide—leprosy	7.12e-05	0.00228	CcSEcCtD
Lenalidomide—Pharyngitis—Thalidomide—leprosy	7.1e-05	0.00228	CcSEcCtD
Lenalidomide—Urinary tract disorder—Thalidomide—leprosy	7.07e-05	0.00227	CcSEcCtD
Lenalidomide—Oedema peripheral—Thalidomide—leprosy	7.05e-05	0.00226	CcSEcCtD
Lenalidomide—Urethral disorder—Thalidomide—leprosy	7.02e-05	0.00225	CcSEcCtD
Lenalidomide—Visual impairment—Thalidomide—leprosy	6.9e-05	0.00221	CcSEcCtD
Lenalidomide—Erythema multiforme—Thalidomide—leprosy	6.77e-05	0.00217	CcSEcCtD
Lenalidomide—Eye disorder—Thalidomide—leprosy	6.69e-05	0.00214	CcSEcCtD
Lenalidomide—Tinnitus—Thalidomide—leprosy	6.67e-05	0.00214	CcSEcCtD
Lenalidomide—Cardiac disorder—Thalidomide—leprosy	6.64e-05	0.00213	CcSEcCtD
Lenalidomide—Angiopathy—Thalidomide—leprosy	6.49e-05	0.00208	CcSEcCtD
Lenalidomide—Immune system disorder—Thalidomide—leprosy	6.47e-05	0.00207	CcSEcCtD
Lenalidomide—Mediastinal disorder—Thalidomide—leprosy	6.45e-05	0.00207	CcSEcCtD
Lenalidomide—Chills—Thalidomide—leprosy	6.42e-05	0.00206	CcSEcCtD
Lenalidomide—Arrhythmia—Thalidomide—leprosy	6.39e-05	0.00205	CcSEcCtD
Lenalidomide—Alopecia—Thalidomide—leprosy	6.33e-05	0.00203	CcSEcCtD
Lenalidomide—Vomiting—Dapsone—leprosy	6.32e-05	0.00203	CcSEcCtD
Lenalidomide—Mental disorder—Thalidomide—leprosy	6.27e-05	0.00201	CcSEcCtD
Lenalidomide—Malnutrition—Thalidomide—leprosy	6.23e-05	0.002	CcSEcCtD
Lenalidomide—Headache—Dapsone—leprosy	6.22e-05	0.002	CcSEcCtD
Lenalidomide—Flatulence—Thalidomide—leprosy	6.14e-05	0.00197	CcSEcCtD
Lenalidomide—Tension—Thalidomide—leprosy	6.11e-05	0.00196	CcSEcCtD
Lenalidomide—Dysgeusia—Thalidomide—leprosy	6.1e-05	0.00196	CcSEcCtD
Lenalidomide—Nervousness—Thalidomide—leprosy	6.05e-05	0.00194	CcSEcCtD
Lenalidomide—Back pain—Thalidomide—leprosy	6.03e-05	0.00193	CcSEcCtD
Lenalidomide—Muscle spasms—Thalidomide—leprosy	5.99e-05	0.00192	CcSEcCtD
Lenalidomide—Nausea—Dapsone—leprosy	5.9e-05	0.00189	CcSEcCtD
Lenalidomide—Vision blurred—Thalidomide—leprosy	5.87e-05	0.00188	CcSEcCtD
Lenalidomide—Tremor—Thalidomide—leprosy	5.84e-05	0.00187	CcSEcCtD
Lenalidomide—Ill-defined disorder—Thalidomide—leprosy	5.78e-05	0.00185	CcSEcCtD
Lenalidomide—Anaemia—Thalidomide—leprosy	5.76e-05	0.00185	CcSEcCtD
Lenalidomide—Agitation—Thalidomide—leprosy	5.73e-05	0.00184	CcSEcCtD
Lenalidomide—Angioedema—Thalidomide—leprosy	5.69e-05	0.00183	CcSEcCtD
Lenalidomide—Malaise—Thalidomide—leprosy	5.62e-05	0.0018	CcSEcCtD
Lenalidomide—Vertigo—Thalidomide—leprosy	5.6e-05	0.00179	CcSEcCtD
Lenalidomide—Syncope—Thalidomide—leprosy	5.59e-05	0.00179	CcSEcCtD
Lenalidomide—Leukopenia—Thalidomide—leprosy	5.58e-05	0.00179	CcSEcCtD
Lenalidomide—ABCB1—testis—leprosy	5.51e-05	0.00312	CbGeAlD
Lenalidomide—Palpitations—Thalidomide—leprosy	5.51e-05	0.00177	CcSEcCtD
Lenalidomide—Loss of consciousness—Thalidomide—leprosy	5.48e-05	0.00176	CcSEcCtD
Lenalidomide—Cough—Thalidomide—leprosy	5.44e-05	0.00174	CcSEcCtD
Lenalidomide—ABCB1—nervous system—leprosy	5.41e-05	0.00306	CbGeAlD
Lenalidomide—Hypertension—Thalidomide—leprosy	5.38e-05	0.00172	CcSEcCtD
Lenalidomide—Chest pain—Thalidomide—leprosy	5.31e-05	0.0017	CcSEcCtD
Lenalidomide—Myalgia—Thalidomide—leprosy	5.31e-05	0.0017	CcSEcCtD
Lenalidomide—Arthralgia—Thalidomide—leprosy	5.31e-05	0.0017	CcSEcCtD
Lenalidomide—Anxiety—Thalidomide—leprosy	5.29e-05	0.00169	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	5.27e-05	0.00169	CcSEcCtD
Lenalidomide—Discomfort—Thalidomide—leprosy	5.24e-05	0.00168	CcSEcCtD
Lenalidomide—Dry mouth—Thalidomide—leprosy	5.19e-05	0.00166	CcSEcCtD
Lenalidomide—Confusional state—Thalidomide—leprosy	5.13e-05	0.00164	CcSEcCtD
Lenalidomide—Oedema—Thalidomide—leprosy	5.09e-05	0.00163	CcSEcCtD
Lenalidomide—Infection—Thalidomide—leprosy	5.05e-05	0.00162	CcSEcCtD
Lenalidomide—Shock—Thalidomide—leprosy	5e-05	0.0016	CcSEcCtD
Lenalidomide—Nervous system disorder—Thalidomide—leprosy	4.99e-05	0.0016	CcSEcCtD
Lenalidomide—Thrombocytopenia—Thalidomide—leprosy	4.98e-05	0.0016	CcSEcCtD
Lenalidomide—Tachycardia—Thalidomide—leprosy	4.96e-05	0.00159	CcSEcCtD
Lenalidomide—Skin disorder—Thalidomide—leprosy	4.94e-05	0.00158	CcSEcCtD
Lenalidomide—Hyperhidrosis—Thalidomide—leprosy	4.92e-05	0.00158	CcSEcCtD
Lenalidomide—Anorexia—Thalidomide—leprosy	4.85e-05	0.00155	CcSEcCtD
Lenalidomide—Hypotension—Thalidomide—leprosy	4.75e-05	0.00152	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Thalidomide—leprosy	4.63e-05	0.00149	CcSEcCtD
Lenalidomide—Insomnia—Thalidomide—leprosy	4.6e-05	0.00147	CcSEcCtD
Lenalidomide—Paraesthesia—Thalidomide—leprosy	4.57e-05	0.00146	CcSEcCtD
Lenalidomide—Dyspnoea—Thalidomide—leprosy	4.53e-05	0.00145	CcSEcCtD
Lenalidomide—Somnolence—Thalidomide—leprosy	4.52e-05	0.00145	CcSEcCtD
Lenalidomide—Dyspepsia—Thalidomide—leprosy	4.48e-05	0.00144	CcSEcCtD
Lenalidomide—Decreased appetite—Thalidomide—leprosy	4.42e-05	0.00142	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Thalidomide—leprosy	4.39e-05	0.00141	CcSEcCtD
Lenalidomide—Fatigue—Thalidomide—leprosy	4.38e-05	0.00141	CcSEcCtD
Lenalidomide—Constipation—Thalidomide—leprosy	4.35e-05	0.00139	CcSEcCtD
Lenalidomide—Pain—Thalidomide—leprosy	4.35e-05	0.00139	CcSEcCtD
Lenalidomide—Feeling abnormal—Thalidomide—leprosy	4.19e-05	0.00134	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Thalidomide—leprosy	4.16e-05	0.00133	CcSEcCtD
Lenalidomide—Urticaria—Thalidomide—leprosy	4.04e-05	0.0013	CcSEcCtD
Lenalidomide—Body temperature increased—Thalidomide—leprosy	4.02e-05	0.00129	CcSEcCtD
Lenalidomide—Abdominal pain—Thalidomide—leprosy	4.02e-05	0.00129	CcSEcCtD
Lenalidomide—Hypersensitivity—Thalidomide—leprosy	3.75e-05	0.0012	CcSEcCtD
Lenalidomide—Asthenia—Thalidomide—leprosy	3.65e-05	0.00117	CcSEcCtD
Lenalidomide—Pruritus—Thalidomide—leprosy	3.6e-05	0.00115	CcSEcCtD
Lenalidomide—Diarrhoea—Thalidomide—leprosy	3.48e-05	0.00112	CcSEcCtD
Lenalidomide—Dizziness—Thalidomide—leprosy	3.36e-05	0.00108	CcSEcCtD
Lenalidomide—Vomiting—Thalidomide—leprosy	3.23e-05	0.00104	CcSEcCtD
Lenalidomide—Rash—Thalidomide—leprosy	3.21e-05	0.00103	CcSEcCtD
Lenalidomide—Dermatitis—Thalidomide—leprosy	3.2e-05	0.00103	CcSEcCtD
Lenalidomide—Headache—Thalidomide—leprosy	3.19e-05	0.00102	CcSEcCtD
Lenalidomide—Nausea—Thalidomide—leprosy	3.02e-05	0.000968	CcSEcCtD
